CA2574959A1 - Antimicrobial peptides derived from cap18 - Google Patents

Antimicrobial peptides derived from cap18 Download PDF

Info

Publication number
CA2574959A1
CA2574959A1 CA002574959A CA2574959A CA2574959A1 CA 2574959 A1 CA2574959 A1 CA 2574959A1 CA 002574959 A CA002574959 A CA 002574959A CA 2574959 A CA2574959 A CA 2574959A CA 2574959 A1 CA2574959 A1 CA 2574959A1
Authority
CA
Canada
Prior art keywords
use according
terminal part
compounds
bacterial
infection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002574959A
Other languages
English (en)
French (fr)
Inventor
Johannes Jakobus Grote
Jan Wouter Drijfhout
Pieter Sicco Hiemstra
Maartje Johanna Nell
Marcel Jan Vonk
Guido Vincent Bloemberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
OctoPlus Sciences BV
Leids Universitair Medisch Centrum LUMC
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2574959A1 publication Critical patent/CA2574959A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/04—Nitro compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
CA002574959A 2004-07-28 2005-07-26 Antimicrobial peptides derived from cap18 Abandoned CA2574959A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP04077175A EP1621205A1 (en) 2004-07-28 2004-07-28 Antimicrobial peptides derived from CAP18
EP04077175.0 2004-07-28
PCT/NL2005/000545 WO2006011792A2 (en) 2004-07-28 2005-07-26 Antimicrobial peptides derived from cap18

Publications (1)

Publication Number Publication Date
CA2574959A1 true CA2574959A1 (en) 2006-02-02

Family

ID=34928414

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002574959A Abandoned CA2574959A1 (en) 2004-07-28 2005-07-26 Antimicrobial peptides derived from cap18

Country Status (11)

Country Link
US (2) US7803756B2 (enExample)
EP (3) EP1621205A1 (enExample)
JP (1) JP2008508265A (enExample)
KR (1) KR20070050941A (enExample)
CN (1) CN101018563A (enExample)
AU (1) AU2005267651B2 (enExample)
BR (1) BRPI0513856A (enExample)
CA (1) CA2574959A1 (enExample)
NZ (1) NZ553175A (enExample)
RU (1) RU2392962C2 (enExample)
WO (1) WO2006011792A2 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1621205A1 (en) * 2004-07-28 2006-02-01 OctoPlus Technologies B.V. Antimicrobial peptides derived from CAP18
US20100209411A1 (en) 2006-12-01 2010-08-19 Laclede, Inc. Use of hydrolytic and oxidative enzymes to dissolve biofilm in ears
WO2009015336A2 (en) 2007-07-25 2009-01-29 Biolex Therapeutics, Inc. Controlled release interferon drug products and treatment of hcv infection using same
US20100184684A1 (en) * 2009-01-06 2010-07-22 C3 Jian, Inc. Antibacterial and antifungal peptides
AU2010306940A1 (en) 2009-10-12 2012-06-07 Smith, Larry Methods and compositions for modulating gene expression using oligonucleotide based drugs administered in vivo or in vitro
RU2434880C1 (ru) * 2010-07-21 2011-11-27 Общество С Ограниченной Ответственностью "Биохарт" Полипептид, имеющий антибактериальную активность и пригодный для получения лекарственных средств для лечения бактериальных инфекций человека
KR20200023521A (ko) * 2012-05-09 2020-03-04 콘트라펙트 코포레이션 박테리오파지 리신을 이용한 생물막의 예방, 붕괴 및 치료
AU2014263279B2 (en) * 2013-05-10 2018-02-15 Academisch Ziekenhuis Leiden H.O.D.N. Lumc Antimicrobial peptide
US9387189B2 (en) 2013-05-22 2016-07-12 Professional Compounding Centers Of America (Pcca) Antibiotic composition comprising a chemotactic agent and a nutrient dispersion
WO2015075406A1 (en) * 2013-11-19 2015-05-28 Lipopeptide Ab New treatment of chronic ulcers
AU2014360942B2 (en) * 2013-12-12 2018-12-13 Academisch Medisch Centrum Antimicrobial peptide and uses thereof
WO2015164289A1 (en) * 2014-04-21 2015-10-29 Cidara Therapeutics, Inc. Compositions and methods for the treatment of fungal infections
US20250034218A1 (en) * 2021-09-21 2025-01-30 Biomedit, Llc Antimicrobial peptides

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4037525B2 (ja) * 1998-03-25 2008-01-23 生化学工業株式会社 新規抗菌性ペプチド
MXPA05008080A (es) * 2003-01-28 2006-02-08 Octoplus Technologies B V Inhibidores peptidicos de toxinas derivadas de la ll-37.
CN1878789A (zh) 2003-10-21 2006-12-13 加利福尼亚大学董事会 人凯萨林菌素抗微生物肽
EP1621205A1 (en) * 2004-07-28 2006-02-01 OctoPlus Technologies B.V. Antimicrobial peptides derived from CAP18

Also Published As

Publication number Publication date
BRPI0513856A (pt) 2008-05-20
NZ553175A (en) 2009-10-30
WO2006011792A3 (en) 2006-09-14
AU2005267651B2 (en) 2010-05-27
EP2221061A1 (en) 2010-08-25
US20080249022A1 (en) 2008-10-09
US20110053835A1 (en) 2011-03-03
US7803756B2 (en) 2010-09-28
EP1784206A2 (en) 2007-05-16
AU2005267651A1 (en) 2006-02-02
EP1621205A1 (en) 2006-02-01
CN101018563A (zh) 2007-08-15
JP2008508265A (ja) 2008-03-21
RU2392962C2 (ru) 2010-06-27
KR20070050941A (ko) 2007-05-16
WO2006011792A2 (en) 2006-02-02
RU2007107390A (ru) 2008-09-10

Similar Documents

Publication Publication Date Title
US20110053835A1 (en) Antimicrobial peptides derived from cap18
AU2004207118B2 (en) Peptide inhibitors of toxins derived from LL-37
CN114341160B (zh) 包含赖氨酸替换的romo1来源抗微生物肽及其变体
JP2015028082A (ja) 抗菌性カチオン性ペプチドおよびそれらの処方物
US11266712B2 (en) Antimicrobial peptides and methods of using the same
US20210324359A1 (en) Use of gram-negative lysin-antimicrobial peptide (amp) polypeptide constructs in treating endocarditis
CN101878226B (zh) 精氨酸取代的新型合成肽及其应用
HK1102693A (en) Antimicrobial peptides derived from cap18
JP6506317B2 (ja) ペプチドおよびその使用
TW201019954A (en) Treatment of intracellular bacterial infections
HK1088613B (en) Peptide inhibitors of toxins derived from ll-37
AU2018445889B2 (en) Antimicrobial peptides and methods of using the same

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued

Effective date: 20140725